History
  • No items yet
midpage
Acorda Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
78 F. Supp. 3d 572
D. Del.
2015
Read the full case

Background

  • Defendants Mylan Pharma and Mylan Inc. moved to dismiss for lack of personal jurisdiction under Rule 12(b)(2).
  • Court held it has personal jurisdiction over Mylan Pharma based on consent via Delaware registration and to a lesser extent on specific jurisdiction; general jurisdiction over Mylan Inc. denied pending jurisdictional discovery.
  • Mylan Pharma registered to do business in Delaware in 2010, appointed a registered agent, and is thus deemed to have consented to Delaware courts’ jurisdiction.
  • Mylan Inc. is not registered to do business in Delaware and has not consented to general jurisdiction; plaintiffs may pursue jurisdictional discovery to examine agency theories and Mylan Inc.’s relation to Mylan Pharma.
  • Plaintiffs filed seven related Ampyra patent-ANDA suits in the District of Delaware; this case was filed July 16, 2014 after notice of an ANDA filing.
  • Court ordered limited jurisdictional discovery on whether Mylan Inc. is subject to specific jurisdiction via agency theory and denied general jurisdiction for Mylan Inc. pending discovery.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Mylan Pharma is subject to general jurisdiction in Delaware Consent via registration renders general jurisdiction Daimler limits general jurisdiction to at-home cores or consent via contracts Yes, based on consent via Delaware registration
Whether Mylan Inc. is subject to general jurisdiction in Delaware Consent via parent-subsidiary control and appointment tactics Not at home; no registration or consent No general jurisdiction; jurisdictional discovery allowed for agency theory
Whether Mylan Pharma is subject to specific jurisdiction in Delaware DA and letters directed to Delaware; injury anticipated in forum Arguments limited; no in-forum mailing Yes, court may exercise specific jurisdiction over Mylan Pharma
Whether jurisdictional discovery is appropriate to determine specific jurisdiction over Mylan Inc. Agency theory may establish jurisdiction over Inc. Insufficient current facts; discovery needed Granted for limited jurisdictional discovery

Key Cases Cited

  • Daimler AG v. Bauman, 134 S. Ct. 746 (U.S. 2014) (limits general jurisdiction to at-home corporations; supports consent-based approach not foreclosed)
  • Sternberg v. O’Neil, 550 A.2d 1105 (Del. 1988) (registration/statutory consent to jurisdiction via agent appointment)
  • Continental Casualty Co. v. American Home Assurance Co., 61 F. Supp. 2d 128 (D. Del. 1999) (recognizes consent via registration as basis for general jurisdiction)
  • International Shoe Co. v. Washington, 326 U.S. 310 (1945) (establishes due process minimum contacts framework)
  • World-Wide Volkswagen Corp. v. Woodson, 444 U.S. 286 (1980) (predictability and fair play in jurisdiction analysis; specific jurisdiction focus)
  • Pennsylvania Fire Insurance Co. v. Gold Issue Mining & Milling Co., 243 U.S. 93 (1922) (agency/consent via appointment of agent to receive process)
  • Shaffer v. Heitner, 433 U.S. 186 (1977) (distinguishes consent-based jurisdiction from general in rem/post constitutional framework)
Read the full case

Case Details

Case Name: Acorda Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
Court Name: District Court, D. Delaware
Date Published: Jan 14, 2015
Citation: 78 F. Supp. 3d 572
Docket Number: Civil Action No. 14-935-LPS
Court Abbreviation: D. Del.